NASDAQ:TYME - Tyme Technologies Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.60
▲ +0.02 (3.47%)

This chart shows the closing price for TYME by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Tyme Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TYME and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TYME

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Tyme Technologies in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.60.

This chart shows the closing price for TYME for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Tyme Technologies. This rating has held steady since April 2021, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/28/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/26/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/24/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/24/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/21/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/20/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/19/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/21/2020HC WainwrightReiterated RatingBuy$9.50High
2/6/2020HC WainwrightReiterated RatingBuy$9.50High
8/12/2019HC WainwrightInitiated CoverageBuyHigh
2/26/2019HC WainwrightSet Price TargetBuy$10.00High
1/18/2019HC WainwrightSet Price TargetBuy$10.00High
11/7/2018HC WainwrightReiterated RatingBuy$10.00Low
10/11/2018HC WainwrightReiterated RatingBuy$9.50High
2/8/2018HC WainwrightReiterated RatingBuy ➝ Buy$8.00 ➝ $9.50High
12/15/2017HC WainwrightInitiated CoverageBuy ➝ Buy$8.00High
11/17/2017Evercore ISIInitiated CoverageOutperform$7.00N/A
(Data available from 1/19/2017 forward)

News Sentiment Rating

0.53 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/23/2021
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/23/2021
  • 1 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 3 very negative mentions
8/22/2021
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
9/21/2021
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
10/21/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 2 very negative mentions
11/20/2021
  • 4 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/20/2021
  • 4 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 2 very negative mentions
1/19/2022

Current Sentiment

  • 4 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 2 very negative mentions
Tyme Technologies logo
Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ.
Read More

Today's Range

Now: $0.60
Low: $0.56
High: $0.60

50 Day Range

MA: $0.72
Low: $0.58
High: $0.95

52 Week Range

Now: $0.60
Low: $0.56
High: $4.99

Volume

862,975 shs

Average Volume

727,204 shs

Market Capitalization

$102.81 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.87

Frequently Asked Questions

What sell-side analysts currently cover shares of Tyme Technologies?

The following Wall Street sell-side analysts have issued stock ratings on Tyme Technologies in the last twelve months:
View the latest analyst ratings for TYME.

What is the current price target for Tyme Technologies?

0 Wall Street analysts have set twelve-month price targets for Tyme Technologies in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Tyme Technologies in the next year.
View the latest price targets for TYME.

What is the current consensus analyst rating for Tyme Technologies?

Tyme Technologies currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for TYME.

How do I contact Tyme Technologies' investor relations team?

Tyme Technologies' physical mailing address is 17 STATE STREET 7TH FLOOR, NEW YORK NY, 10004. The company's listed phone number is (212) 461-2315 and its investor relations email address is [email protected] The official website for Tyme Technologies is www.tymeinc.com.